Protein Synthesis during Sleep Consolidates Cortical Plasticity In Vivo  by Seibt, Julie et al.
Protein Synthesis during SleCurrent Biology 22, 676–682, April 24, 2012 ª2012 Elsevier Ltd All rights reserved DOI 10.1016/j.cub.2012.02.016Report
ep
Consolidates Cortical Plasticity In VivoJulie Seibt,1,3 Michelle C. Dumoulin,1 Sara J. Aton,1
Tammi Coleman,1 Adam Watson,1 Nirinjini Naidoo,2
and Marcos G. Frank1,*
1Department of Neuroscience
2Center for Sleep and Circadian Neurobiology
Perelman School of Medicine, University of Pennsylvania,
Philadelphia, PA 19104-6074, USA
3Institute of Physiology, University of Bern, Bu¨hlplatz 5,
CH-3012 Bern, Switzerland
Summary
Sleep consolidates experience-dependent brain plasticity,
but the precise cellular mechanisms mediating this process
are unknown [1]. De novo cortical protein synthesis is one
possible mechanism. In support of this hypothesis, sleep
is associated with increased brain protein synthesis [2, 3]
and transcription of messenger RNAs (mRNAs) involved in
protein synthesis regulation [4, 5]. Protein synthesis in
turn is critical for memory consolidation and persistent
forms of plasticity in vitro and in vivo [6, 7]. However, it is
unknown whether cortical protein synthesis in sleep serves
similar functions. We investigated the role of protein
synthesis in the sleep-dependent consolidation of a classic
form of cortical plasticity in vivo (ocular dominance plas-
ticity, ODP; [8, 9]) in the cat visual cortex. We show that
intracortical inhibition of mammalian target of rapamycin
(mTOR)-dependent protein synthesis during sleep abol-
ishes consolidation but has no effect on plasticity induced
during wakefulness. Sleep also promotes phosphorylation
of protein synthesis regulators (i.e., 4E-BP1 and eEF2) and
the translation (but not transcription) of key plasticity related
mRNAs (ARC and BDNF). These findings show that sleep
promotes cortical mRNA translation. Interruption of this
process has functional consequences, because it abolishes
the consolidation of experience in the cortex.
Results and Discussion
Protein Synthesis during Sleep, But NotWake, Is Important
for Ocular Dominance Plasticity
Ocular dominance plasticity (ODP) refers to plastic changes
in visual cortical circuits triggered by transiently blocking
patterned vision in one eye (monocular deprivation, MD)
[8, 9]. ODP appears to involve Hebbian and nonHebbian forms
of synaptic plasticity [10], many of which require de novo
protein synthesis to be consolidated [11]. We have previously
shown thatODP can be divided into an induction phase (during
waking) and a consolidation phase (during sleep) [9, 12]. What
is not known, however, is the relative role of protein synthesis
in the waking and sleeping phases of ODP.
To address this issue, we inhibited protein synthesis in
visual cortex (V1) with rapamycin (RAPA), which interferes
with the Raptor/mTOR complex (mTORC1) [13], preventing*Correspondence: mgf@mail.med.upenn.edumTORC1-mediated cap-dependent translation initiation [14].
mTORC1 is crucial for consolidation of several forms of plas-
ticity [15], but its role in ODP has not been investigated. We
first determined whether mTORC1-mediated translation was
required for the sleep-dependent consolidation of ODP. These
animals underwent 6 hr of MD (while awake) and then were
allowed to sleep ad lib for 6 hr during which time RAPA or
vehicle (VEH) were intracortically infused in V1 (MD + sleep in
Figure 1A). The animals were then immediately assessed for
changes in ODP using microelectrode recording of single V1
neurons (see Supplemental Experimental Procedures avail-
able online).
When infused during post-MD sleep, RAPA inhibited
mTORC1 signaling as measured by phosphorylation of its
direct downstream target; eukaryotic initiation factor 4E
(eIF4E)-binding protein 1 (4E-BP1) (Figure 1B; see Supple-
mental Experimental Procedures: Validation of RAPA Effi-
cacy). RAPA also reduced cortical expression of several
plasticity related proteins (ARC, BDNF, PSD-95) and the trans-
lation factor eukaryote elongation factor 1A (eEF1A) (Fig-
ure 1B). RAPA also completely abolished ODP consolidation.
Microelectrode recording and corresponding ocular domi-
nance (OD) histograms [16] showed that the normal sleep-
dependent shift in visual responses toward the nondeprived
eye (NDE) did not occur in neurons infused with RAPA. Sleep
following MD in the VEH-infused animals increased the
proportion of cells more strongly activated by stimulation of
the NDE (OD scores of 1–3); this did not occur in cells infused
with RAPA (Figure 1C). This was confirmed using the nonde-
prived bias index (NBI), a weighted average of the OD histo-
gram [9, 12, 16] (Supplemental Experimental Procedures).
The NBI, which ranges from 0.5 (equal dominance of both
eyes) to 1 (total dominance by the NDE), showed that the
effects of sleep on ODP were abolished in RAPA infused
neurons (Figures 1D and 1E). As shown in Table S1, RAPA pre-
vented the normal sleep-dependent potentiation of NDE
circuits and depression of deprived-eye (DE) circuits [12].
This indicated that both plastic changes require sleep-depen-
dent protein synthesis.
These results are unlikely explained by nonspecific effects
of RAPA. First, RAPA is highly selective for mTORC1 rather
than mTORC2, the mTOR complex that influences cell survival
and cytoskeletal organization [14]. However, because pro-
longed exposure to RAPA might also alter mTORC2 function
[17], we inactivated a downstream mediator of mTORC2
function (Akt; [18]). The selective Akt inhibitor (LY294002)
had no effect on ODP consolidation (Figures S1D and S1E).
This result is consistent with previous findings indicating that
downstream targets of mTORC2 (i.e., PKC) are not essential
for ODP [19]. Second, RAPA had no effect on ongoing neuronal
(EEG) activity or sleep behavior and did not produce abnormal-
ities in sensory processing in V1 neurons (Figures S1A and
S1C; Table S1).
To further examine the role of protein synthesis in ODP
consolidation, we next infused cycloheximide (CHX) during
post-MD sleep. CHX disrupts the translocation-elongation
step of protein synthesis and globally reduces cortical protein
synthesis in vivo [20]. CHX also completely blocked ODP
Figure 1. Cortical Plasticity during Sleep, But Not Wake, Requires Protein Synthesis via mTORC1
(A) Experimental designs for the main groups. V1 was continuously infused for 6 hr with VEH or RAPA in the MD + sleep andMD only groups during sleep or
wake, respectively. In an additional group, RAPA was infused during 1 hr of post-MD sleep to measure the efficacy of RAPA on cortical mRNA translation
(MD + 1 hr sleep). Arrowhead represents ODP assessment (single units) or tissue harvesting (western blot).
(B) RAPA infusion during 1 hr post-MD sleep inhibits phosphorylation of the direct downstream target of mTORC1, 4E-BP1, and expression of several
proteins implicated in synaptic plasticity (Arc, PSD-95, and BDNF) or translation regulator (eEF1A) (represented as normalized phospho/tot or expression
level relative to far site, see Supplemental Experimental Procedures) near the infusion site (near versus far, ***p < 0.001, **p < 0.01, *p < 0.05 t test, n = 10
hemispheres). Representative western blots are shown.
(C) OD histograms near the infusion site in MD only and MD + sleep groups infused with RAPA or VEH. OD histogram from normal animals is on the left. N,
number of hemispheres (total number of neurons).
(D) Quantitative scalar measure of OD. NBI values calculated near the infusion site show that MDonly induced a shift in ODP in favor of the NDE compared to
animals with normal vision (normal); this was unaffected by RAPA. A subsequent 6 hr ad lib sleep period further increases ODP in VEH infused animals, but
this was blocked in the RAPA group. One-way analysis of variance (ANOVA); F = 9.13, p < 0.001, versus normal: ***p < 0.001, **p < 0.01, *p < 0.05; versusMD+
sleep VEH: ##p < 0.01, #p < 0.05, Holm-Sidak test.
(E) NBI values near the RAPA infusion sites were reduced compared to far sites only in theMD + sleep group (one-way ANOVA; F = 5.43, p = 0.004, ##p < 0.01,
Holm-Sidak test). No differences were found between near and far sites for VEH-and RAPA-infused hemispheres after MD only infusion (N.S.). All values are
represented as means 6 SEM.
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678consolidation (n = 3 hemispheres, NBI: RAPA, 0.56 6 0.03;
CHX, 0.59 6 0.04, p > 0.05, t test). In contrast to RAPA, CHX
produced abnormalities in cat V1 responses compared to
control animals with normal binocular vision (Table S1). This
may be related to neurotoxic effects of CHX, which not only
globally reduces protein synthesis throughout the cell but
can also inhibit DNA replication [21]. We therefore used
RAPA for all protein-synthesis inhibition experiments.
We next determined whether mTORC1was also required for
the induction of ODP during wakefulness. These animals
underwent 6 hr of MD while awake combined with V1 infusion
of VEH or RAPA (MD only in Figure 1A). Consistent with pre-
vious findings [9, 12], 6 hr of MD in the awake cat induced a
small but significant shift in OD in favor of the NDE. This form
of plasticity, however, was unaffected by RAPA (Figures 1C–
1E). These results demonstrate that, in contrast to sleep-
dependent consolidation, protein synthesis is not required
for the induction of ODP during wakefulness.
Sleep Promotes Translation Initiation
To further explore the relationship between sleep and
messenger RNA (mRNA) translation, we measured sleep-
dependent changes in translation regulation at the initiation
(4E-BP1) and elongation (eukaryotic elongation factor 2;
eEF2) steps. Phosphorylation of 4E-BP1 by mTORC1 relieves
its inhibition on eIF4E; the first and crucial step in cap-depen-
dent translation initiation [14]. 4E-BP1 and eEF2 have also
been directly implicated in persistent forms of synaptic plas-
ticity and memory [6, 11]. However, their roles in sleep-depen-
dent cortical plasticity in vivo have not been explored.
Using western blot, we measured changes in the phosphor-
ylation state of both translation factors in synaptoneurosomal
(SN, enriched in synaptic proteins; Figure 2B) and total (TOT,
whole cell extract) protein fractions (see Supplemental Exper-
imental Procedures) from V1. SN fractions were examined
because rapid translation of preexisting pools of synaptic
mRNAs mediates several forms of persistent plasticity
in vitro [22], but this has not been explored in sleep-dependent
plasticity. Using an experimental design similar to the one
used for RAPA infusion, cats were divided into the following
groups: 6 hr of MD only (in awake cats) or 6 hr of MD combined
with 1, 2, or 6 hr of ad lib sleep in complete darkness (Fig-
ure 2A). Control groups consisted of animals treated exactly
the same except that binocular vision was left intact (noMD).
This group would determine whether molecular changes
observed after MD were specifically due to synaptic remodel-
ing or, instead, processes generally promoted either by wake
or sleep (see Tables S2–S4 for details on group formation)
[12]. Following these procedures, the animals were sacrificed
and V1 cortices harvested.
We found a simultaneous increase in phosphorylation of
4E-BP1 and eEF2 after 1–2 hr of sleep. These changes
appeared to be compartmentalized; increased translation
initiation (i.e., increased p-4E-BP1) occurred preferentially in
SN fractions (Figure 2C) and decreased protein elongation
(i.e., increased p-eEF2) occurred preferentially in TOT protein
fractions and specifically in the MD group (Figure 2D). We
also found a 36.5% increase in the phosphorylation (at
Ser209) of the key cap-dependent initiation factor eIF4E [14]
after 1 hr of sleep in theMD group, but this did not reach signif-
icance (data not shown).When the samples shown in Figure 1B
were tested for eEF2, we found no effect of RAPA on eEF2
phosphorylation (RAPA far site: 1.05 6 0.05 versus RAPA
near site: 1.18 6 0.11, p = 0.3, n = 10, t test). This suggeststhat in the remodeling visual cortex, eEF2 is not a downstream
target of mTORC1 [23] and is probably activated by another
pathway. ERK for example is also activated in post-MD sleep
[12] and can also phosphorylate eEF2 [24].
These results indicate that sleep promotes translation initia-
tion (i.e., p-4E-BP1) andwhen V1 is triggered to remodel, this is
accompaniedbyadecrease in protein elongation (i.e., p-eEF2).
Similar coregulation and compartmentalization of initiation
and elongation factors are also reported following in vivo
BDNF-mediated long-term potentiation (LTP) [25] and during
long-term facilitation in Aplysia [26], suggesting that this is a
conservedmechanism in persistent forms of plasticity. In addi-
tion, this may also enhance the translation of specific pools of
mRNAs [27]. This is because decreasing the elongation step
(via eEF2 phosphorylation) may shift the rate-limiting step in
protein synthesis away from initiation towardelongation,which
increases the translation of what are termed ‘‘poorly initiated
proteins’’ (e.g., ARC) [27]. Our findings indicate that these latter
events may be specifically promoted by sleep.
Translation and Transcription of ARC and BDNF Are
Divided across Wake and Sleep
Our results suggest that mRNAs important for plasticity are
translated during sleep. We therefore examined sleep-
dependent changes in the translation (and for comparison,
transcription) of two mRNAs centrally involved in Hebbian and
nonHebbian formsof plasticity [28, 29] andwhichwere reduced
(as proteins) by RAPA during sleep (Figure 1B): ARC (also
known asArg3.1) andBDNF. ThesemRNAs are also translated
in LTP (BDNF and ARC) or long-term depression (LTD) proto-
cols (ARC) that trigger phosphorylation of mTORC1 and/or
eEF2 [30, 31] and are important for ODP [32, 33].We also exam-
ined the translationand transcriptionofaCaMKII (i.e.,CAMK2A)
and GLURI (i.e., GRIA1), which, at a protein level, were unaf-
fected by intracortical RAPA infusion (Figure S3A). All four
mRNAs have also been shown to be trafficked to synapses
where they remain untranslated until synaptic plasticity is
induced [22]. Using western blot and quantitative PCR
(qPCR), we measured sleep-dependent changes in the tran-
scription and translation of ARC, BDNF, aCaMKII, and GLURI
from cortices used in Figure 2.
In agreement with studies in adult rodents [4, 34], ARC and
BDNF mRNA transcript levels were reduced after sleep (in
both noMD and MD groups, Figure 3A). In contrast to these
studies, the corresponding proteinswere transiently but signif-
icantly upregulated in the first (BDNF: MD + sleep; Figure 3C)
and second hr (ARC: noMD + sleep andMD + sleep; Figure 3B)
of sleep, declining only after 6 hr (Figures 3B and 3C). This
corresponded to the period of enhanced translation initiation
in sleep (Figure 2) These findings indicate that the transcription
and translation of ARC and BDNF do not always occur in
parallel during sleep and that the first few hours of sleep may
be a time of accelerated protein synthesis. In contrast, there
wereonlymodest changes inaCaMKIIandGLURI transcription
and translation across sleep and wake (Figure S3B). These
latter results indicate that not all transcripts are regulated in a
state-dependent fashion and further suggest that only a subset
of proteins is actively translated during sleep.
Translational Events Are Promoted by Sleep; Transcription
by Patterned Vision during Wakefulness
We next determined whether the reduction in mRNAs
observed after sleep was merely an indirect effect of reducing
visual input to V1 rather than an active repression of
Figure 2. Sleep and Waking Experience Affect Phosphorylation of Translation Factors
(A) Experimental design for the main groups: MD (black bars) or normal binocular vision (noMD control: gray bars) was combined with 0 (i.e., MD only and
noMD only) or 1, 2, or 6 hr ad lib sleep. V1 was then harvested and processed separately for total mRNA extraction (see Figure 3A) and TOT and SN protein
extraction.
(B) Validation of SN enrichment. Representative immunoblots showing enrichment of PSD-95 and GluRI protein level [37], decreased b-tubulin [38], and
unchanged aCaMKII [39] expression in the SN preparation compared to total protein extract in the same V1 sample. Equal amounts (40 mg) of protein
were loaded for both fractions.
(C and D) Representative western bots (left panels) and quantification of pooled data (right graphs) showing changes in phosphorylation state for 4E-BP1 (C)
and eEF2 (D) in SN and TOT protein fractions.
(C) Translation initiation, via 4E-BP1 phosphorylation (Ser65), increased in the first hr of sleep in both noMD and MD groups, but this was only significant in
the SN fraction (one-way ANOVA; noMD groups, H = 15.33, p = 0.002; MD groups, H = 12.75, p = 0.005, *p < 0.05 Dunn’s test). In the TOT fraction there was
a significant decrease in p-4E-BP1 after 6 hr of sleep compared to wake in both noMD andMD groups (one-way ANOVA; noMD groups, H = 11.69, p = 0.009;
MD groups, H = 10.24, p = 0.017, *p < 0.05 Dunn’s test).
(D) Translation elongation arrest, via eEF2 phosphorylation (Thr56), was enhanced after MD + 1 hr sleep, in the TOT fraction, but not in synaptic enriched
fractions (one-way ANOVA; MD groups, H = 11.29, p = 0.01, *p < 0.05, Dunn’s test).
Normalizing procedures are described in Supplemental Experimental Procedure. Between 8 and 20 samples were used per condition (Table S3 for details).
All values are represented as means 6 SEM.
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vation that ARC and BDNF mRNAs were reduced by MD in
awake animals (relative to noMD animals; Figure 3A). Because
MD reduces visual drive to V1 and reducing visual input
decreases mRNA transcription in V1 [35], we hypothesized
that decreases observed after sleep might also reflect a
decrease in visual input during sleep. To explore this possi-
bility, we examined the effects of 6 hr of binocular deprivation
(BD only; Figure 4A; Supplemental Experimental Procedures)
in awake cats, which does not trigger ODP [8], on ARC andBDNFmRNAs. We also examined FOS (c-fos) mRNA, because
expression of this immediate early gene is a widely used
marker of activity-dependent transcription [36] and because
FOS also decreases during sleep (Figure S4A). Consistent
with our hypothesis, 6 hr of BD in the awake cat reduced
transcription of ARC, BDNF, and FOS to a level observed after
6 hr of sleep (Figure 4B; Figure S4B). This suggests that sleep-
related decreases in ARC, BDNF, and FOS (at least within the
visual cortex) may be passive epiphenomena of sleep unre-
lated to experience-dependent plasticity.
Figure 3. Sleep Promotes Translation, But Not Transcription, of ARC and BDNF
(A) Quantitative PCR for ARC and BDNF (experimental designs shown in Figure 2A). ARC and BDNF expression are reduced during sleep in both noMD and
MD animals compared to wake (one-way ANOVA; noMD groups, H = 24.60, p < 0.001 and H = 21.64, p < 0.001 for ARC and BDNF, respectively; MD groups,
H = 25.89, p < 0.001 and F= 17.63, p < 0.001 forARC andBDNF, respectively; ***p < 0.001, **p < 0.01, *p < 0.05, Holm-Sidak or Dunn’s test where appropriate).
ARC and BDNF expression are reduced by MD compared to noMD animals during wakefulness and in hr 1 and 2 of the ad lib sleep period (###p < 0.001,
##p < 0.01, #p < 0.05; t test or Mann-Whitney test where appropriate).
(B and C) Representative western blots and quantification of pooled data for ARC (B) and BDNF (C) in SN and TOT protein fractions.
(B) ARC protein in both SN and TOT fractions significantly increased in the second hr of sleep (one-way ANOVA; noMD group: TOT, F = 5.17, p = 0.005; SN,
H = 8.97, p = 0.003; MD group: TOT, F = 10.17, p% 0.001; SN, H = 9.2, p = 0.34, ***p < 0.001, *p < 0.05, Holm-Sidak or Dunn’s test where appropriate).
(C) BDNF protein in both SN and TOT fractions significantly increased in the first hr of post-MD sleep (one-way ANOVA; TOT: H = 12.08, p = 0.007; SN:
H = 12.45, p = 0.006, *p < 0.05, Dunn’s test) and declined after 6 hr of sleep in both groups significantly in the noMD group relative to waking (one-way
ANOVA; TOT: H = 8.14, p = 0.043; SN: H = 15.87, p = 0.001, *p < 0.05, Dunn’s test).
Normalizing procedures are described in Supplemental Experimental Procedures. Between 8 and 16 samples were used per condition (Table S4 for details).
All values are represented as means 6 SEM.
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Figures 2 and 3 were sleep-dependent or merely time-depen-
dent. We found that the largest changes in proteins observed
after sleep did not occur when animals were instead kept
awake 1 hr after MD (MD + 1 hr SD; Figures 4A, 4C, and 4D).
Increases in eEF2 and SN 4E-BP1 phosphorylation observed
after sleep did not occur in theMD + 1 hr SD group (Figure 4C).
This was also true for BDNF, where increases in TOT and SN
fractions were no longer significant compared to wakefulness
(Figure 4D). One hr of SD also significantly decreased ARC
protein amounts compared to both the MD + 1 hr sleep and
MD-only group (Figure 4C). Because eEF1A and PSD-95
were also reduced by RAPA during post-MD sleep (Figure 1B),
we examined a subset of these samples for these proteins.
Whereas there were no differences between MD and noMD
conditions, when grouped together as wake only (MD only
and noMDonly), sleep (MD+ 1 hr sleep and noMD+ 1 hr sleep),and sleep-deprived (MD + 1 hr SD), there was a significant
increase (80.34%) in PSD-95 synaptic content after sleep,
which was significantly reduced by 55.4% in the sleep-
deprived group (Figure S4D).There was no effect of vigilance
state on eEF1A synaptic content. Taken together, these results
indicated that protein changes observed after sleep in Figures
2 and 3 were sleep-dependent.
In summary, we show that sleep promotes cortical mRNA
translation and interruption of this process prevents the
consolidation of a canonical form of cortical plasticity in vivo.
These findings are novel for the following reasons. First,
although protein synthesis has been previously shown to be
necessary for ODP [20], we now show that this process specif-
ically occurs during sleep. Second, although it is known that
sleep is associated with heightened brain protein synthesis
[2, 3, 5], ours is the first demonstration that this serves an
important cortical function (i.e., consolidating experience).
Figure 4. Visual Experience Triggers mRNA Transcription But Translation Requires Sleep
(A) Experimental designs. In experiment 1, the role of patterned visual input inARC andBDNF transcriptionwas assessed. Instead ofMD, animals underwent
6 hr of binocular deprivation (BD only) while awake. In experiment 2, the necessity of sleep in cortical protein synthesis was assessed. The MD period was
followed by 1 hr of sleep deprivation (SD) in complete darkness (to prevent any additional visual input) prior to sacrifice (MD+ 1 hr SD). Arrowheads represent
V1 tissue harvest for mRNA (BD) or protein (SN/TOT) extraction (MD + 1 hr SD).
(B) ARC and BDNFmRNA levels were reduced in the BD-only group compared to the MD only and noMD only group (values are reproduced from Figure 3)
(one-way ANOVA;ARC: F = 7.67, p = 0.002;BDNF: F = 18.57, p < 0.001; ***p < 0.001, *p < 0.05, Holm-Sidak test). White reference line represents mean values
from animals that slept 6 hr after the waking period (averaged from the noMD + 6 hr sleep and MD + 6 hr sleep groups shown in Figure 3).
(C) Phosphorylation of 4E-BP1 in SN and eEF2 in TOT fraction is prevented by SD (white bars) (one-way ANOVA; p-4E-BP1-SN: H = 8.76, p = 0.013; p-eEF2-
TOT: H = 8.29, p = 0.016, *p < 0.05 Dunn’s test).
(D) Increases in SN and TOT BDNF protein observed after sleep do not occur after SD (white bars) (one-way ANOVA; BDNF-SN: H = 6.93, p = 0.031; BDNF-
TOT: H = 8.39, p = 0.015, *p < 0.05 Dunn’s test). ARC protein in TOT and SN fractions was also decreased in theMD+ 1 hr SD group compared toMDonly and
MD + 1 hr sleep (one-way ANOVA; TOT: F = 3.56, p = 0.041; SN: F = 3.74, p = 0.036, *p < 0.05 Holm-Sidak test).
For (C) and (D), MD-only group and MD + 1 hr sleep values are reproduced from Figures 2 and 3. Next to each graph are representative corresponding
western blots. ARC and BDNF mRNA levels were not significantly different in the MD + 1 hr SD group to levels observed after 1 hr of sleep (Figure S4C).
Normalizing procedures for changes in mRNA and protein expression (represented as means 6 SEM) are described in Supplemental Experimental
Procedures. Between 6 and 16 samples were used per condition (see Tables S3 and S4 for details).
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wakefulness and its subsequent consolidation during sleep
involve different cellular mechanisms. Protein synthesis is
essential for plastic changes that occur during sleep but
unnecessary for plasticity induced during wake. Lastly, our
findings demonstrate that although experience is required
for the transcription of key plasticity-related mRNAs, their
translation into protein requires sleep. This may represent
a sleep-dependent mechanism that converts labile plastic
changes into more permanent forms.Experimental Procedures
Intracortical Infusion Experiments and Drugs
All cats underwent a standard design to induce ODP as described previ-
ously [9]. Drugs (rapamycin [150 mM], cycloheximide [6 mM], or LY294002
[LY29, 5 mM]) and VEH were infused intracortically at 0.25 ml/min in V1 by
mean of an indwelling cannula. See Table S2 and Supplemental Experi-
mental Procedures for details on group formation and single-unit record-
ings. All animals used in this study were obtained from our colony. All exper-
imental procedures in animals were approved by the University of
Pennsylvania Institutional Animal Care and Use Committee.Sleep Analyses
Polysomnography was used to verify that animals in all groups were equally
awake during the enforced waking period and equally asleep during the
subsequent ad lib sleep period. See Figures S1 and S2 and Supplemental
Experimental Procedures for additional details on sleep analysis.
Protein and mRNA Measures
Control (no MD) or animals undergoing MD were sacrificed after 0, 1, 2, or
6 hr of sleep (Figure 2A). V1 was rapidly removed bilaterally, immediately
frozen on dry ice, and stored at 280C until use. See Supplemental Exper-
imental Procedures and Tables S2–S4 for details on experimental groups
and biochemistry techniques and analysis.
Supplemental Information
Supplemental Information includes four figures, five tables, and Supple-
mental Experimental Procedures and can be found with this article online
at doi:10.1016/j.cub.2012.02.016.
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